This Event is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Event: 1888
Key Event Title
Increased (ectopic) all-trans retinoic acid concentration
Short name
Biological Context
Level of Biological Organization |
---|
Tissue |
Organ term
Key Event Components
Key Event Overview
AOPs Including This Key Event
AOP Name | Role of event in AOP | Point of Contact | Author Status | OECD Status |
---|---|---|---|---|
Ectopic ATRA in fetal testis leads to reduced sperm count | MolecularInitiatingEvent | Terje Svingen (send email) | Under development: Not open for comment. Do not cite |
Taxonomic Applicability
Life Stages
Life stage | Evidence |
---|---|
Fetal | Moderate |
Sex Applicability
Term | Evidence |
---|---|
Male | High |
Female | High |
Key Event Description
Retinoic acid (RA) function and metabolism
RA and retinoid signaling is central for numerous physiological processes, and has important roles within reproduction, vision, development and the immune system (O'Byrne & Blaner, 2013). As an important morphogen, the levels of RA is tightly controlled within tissues both spatially and temporally. Both insufficient and excess RA has proven to cause severe adverse effects (Kedishvili, 2013).
RA homeostasis is maintained by tissue-specific enzymes controlling a 2-step biosynthesis pathway: the precursor retinol is converted into retinaldehyde via retinol dehydrogenases (RDHs). Retinaldehyde dehydrogenases (RALDHs) then irreversibly oxidize retinaldehyde into biologically active RA (reviewed by (Shannon et al, 2017)). RA is removed via degradation to polar inactive metabolites by cytochrome P450 (CYP) family hydroxylases; chiefly CYP26A1, B1 and C1 (Topletz et al, 2015).
RA signals through the nuclear Retinoic Acid Receptors (RARs) and Retinoid X Receptors (RXRs) thereby regulating transcription of target genes (Cunningham & Duester, 2015).
Ectopic RA as Key Event
Inhibition or disruption of any of the enzymes in the RA degradation pathway, including the Cyp26 family, lead to increased concentrations of biologically active RA in target cells.
Equally, application of RA for medical treatments, including for acute promyelocytic leukemia and cystic acne, lead to increased concentrations of biologically active RA in target cells.
How It Is Measured or Detected
In vitro
Indirect measurement of activity and potency of RXRs and RARs is possible via luciferase assays in cell lines, for example (Chassot et al, 2020; Jurutka & Wagner, 2019).
In vivo
Direct measurements of atRA in serum (humans, animals) can be performed by various chromatographic methods (Gundersen et al, 2007), for instance by high performance liquid chromatography (HPLC) (De Leenheer et al, 1982) or liquid chromatography-tandem mass spectrometry (LC-MS) (Morgenstern et al, 2021).
Indirect measurements in animal models can be performed with various reporter assays with RAR-RXR-RARE or RXR-RXR-RARE promoter elements driving expression of reporter proteins. These reporter assays can detect the presence of ATRA in tissues in a semi-quantitative manner. Examples include reporter mouse lines (Carlsen et al, 2021; Rossant et al, 1991; Solomin et al, 1998).
Domain of Applicability
The retinoid signaling pathway is highly evolutionary conserved between vertebrates. This KE is applicable for both mammalian sexes, across developmental stages into adulthood, in numerous cells and tissues and across taxa.